The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.95
Bid: 2.90
Ask: 3.00
Change: -0.17 (-5.57%)
Spread: 0.10 (3.448%)
Open: 3.05
High: 2.88
Low: 2.88
Prev. Close: 3.05
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

7 Dec 2022 13:06

RNS Number : 9449I
ValiRx PLC
07 December 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

gb00blh13c52

Issuer Name

VALIRX PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

nicholas slater

City of registered office (if applicable)

mill hill

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

07-Dec-2022

6. Date on which Issuer notified

07-Dec-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

4.530000

0.000000

4.530000

4087345

Position of previous notification (if applicable)

4.040000

1.760000

5.800000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BLH13C52

3286445

800900

3.640000

0.890000

Sub Total 8.A

4087345

4.530000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

reduced to 4.53%

12. Date of Completion

07-Dec-2022

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUBRORUSUURAA
Date   Source Headline
18th Jun 20134:11 pmRNSManchester One2One Investors Forum - June 26
13th Jun 20137:00 amRNSRe: VAL201 Update
6th Jun 201310:00 amRNSValiRx admitted as founder member of the SSE
25th Apr 20137:00 amRNSNew Patent Granted
22nd Apr 201311:52 amRNSResult of AGM
2nd Apr 20137:00 amRNSUpdate on Developmental and Clinical Activity
28th Mar 20137:01 amRNSFinal Results
21st Feb 20137:00 amRNSRe Commercial Development Update
23rd Jan 20137:00 amRNSAppointment of Medical Monitoring Officer
31st Dec 20127:00 amRNSTotal Voting Rights
22nd Nov 20127:00 amRNSRe: Update
19th Nov 201212:19 pmRNSResult of General Meeting
1st Nov 20121:49 pmRNSPlacing and Notice of General Meeting
11th Oct 20127:00 amRNSre: UK Distribution Agreement
20th Sep 20127:00 amRNSHalf Yearly Report
6th Sep 20127:00 amRNSVAL201 Update re: Breast Cancer Study
2nd Aug 20127:00 amRNSRe: GeneICE and Biomarkers Development Update
29th May 201211:07 amRNSResult of AGM
29th May 20127:00 amRNSUpdate re: Late Pre-clinical Study of VAL201
15th May 20127:00 amRNSNew US Patent Grant
27th Apr 20127:00 amRNSFinal Results
2nd Apr 201212:17 pmRNSDirector/PDMR Shareholding
2nd Apr 20127:00 amRNSPlacing of GBP 900,000 and Director's Dealing
29th Mar 20127:00 amRNSRe Agreement
8th Mar 20127:00 amRNSPeer Review Findings Published re VAL201
14th Feb 20127:00 amRNSEstablishment of Scientific & Advisory Board
2nd Feb 20127:00 amRNSNew European Patent Grant
31st Jan 201210:14 amRNSTotal Voting Rights
5th Jan 20127:00 amRNSAcquisition
15th Dec 20117:00 amRNSNew Patent Grant for GeneICE & VAL101 Update
9th Dec 20114:23 pmRNSRe Volition - Allotment of Shares
24th Nov 20117:00 amRNSHolding(s) in Company
3rd Nov 20117:00 amRNSNew Patent Filing
7th Oct 20118:00 amRNSVolition Update
27th Sep 20117:00 amRNSVolition Update
22nd Sep 20117:00 amRNSHalf Yearly Report
8th Sep 20117:00 amRNSDistribution Agreement
18th Aug 20117:00 amRNSAcquisition of Finnish Non-Trading Company
28th Jul 20117:00 amRNSVAL201 Update
19th Jul 20113:59 pmRNSHolding(s) in Company
14th Jul 20117:00 amRNSDirector/PDMR Shareholding
11th Jul 20117:00 amRNSGrant of Options
23rd Jun 201110:55 amRNSResult of AGM
23rd Jun 20117:00 amRNSAGM Statement
21st Jun 20117:00 amRNSGeneICE Update
10th Jun 20117:00 amRNSVolition - update
2nd Jun 20117:00 amRNSDirectorate Change
31st May 20111:30 pmRNSPublication of Report & Accounts and Notice of AGM
31st May 20117:00 amRNSFinal Results
31st May 20117:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.